Test shows efficacy in detecting neuropathy in diabetes

05/6/2013 | Healio

A study presented at the American Association of Clinical Endocrinologists annual meeting found diabetes patients with neuropathy showed worse electrochemical skin conductance, as measured by the FDA-approved Sudoscan test, than those who did not have neuropathy. Researchers said the test may be useful for early diagnosis of diabetic neuropathy and for evaluation of responses to therapeutic interventions.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations